Acelot will be presenting at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit

Showcasing Preclinical Promise of Targeting TDP-43 in Alzheimer’s Disease

2:00 pm
Conference Day Two - Track Two

Details:

• Reviewing why targeting TDP-43 has historically been difficult

• Outlining the mechanisms of the small molecule to directly target TDP-43

• Characterizing the animal efficacy data

• Discussing TDP-43 prevalence in AD and future directions for clinical translation of this target